Dr. Reginelli studies the impact of different treatment methods and procedural techniques in cardiology, especially concerning patients undergoing invasive procedures like catheterizations and stenting. His research includes the use of medications such as statins for heart patients, as well as blood pressure management to reduce complications after carotid artery procedures. He also evaluates the effectiveness of various stent materials used in treating narrowed arteries, providing insights that help in decision-making for optimal patient care.
Key findings
Implementing intensive blood pressure management after carotid artery stenting reduced bleeding complications from 1.1% to 0%, and severe complications in high-risk patients dropped from 29.4% to 4.2%.
Patients taking statins before undergoing a heart procedure showed a 30% lower risk of heart damage (5.7% vs. 8.1%) and a significantly lower death rate after one year (5.7% vs. 14.8%) when compared to those who did not take statins.
In a study comparing nitinol and stainless-steel stents for carotid interventions, the stroke rates were similar after six months (3.3% for stainless steel, 2.2% for nitinol), but more patients died in the stainless-steel group, highlighting the need for careful material selection.
Frequently asked questions
Does Dr. Reginelli study heart conditions?
Yes, Dr. Reginelli focuses on heart conditions and how various treatments and procedures can improve patient outcomes.
What treatments has Dr. Reginelli researched?
He has researched blood pressure management, the effects of statins on heart patients, and different types of stents used in carotid artery treatments.
Is Dr. Reginelli's work relevant for patients undergoing stenting procedures?
Yes, his research plays a crucial role in enhancing safety and efficacy for patients undergoing stenting procedures and managing related conditions.
Publications in plain English
A quality framework for the role of invasive, non-interventional cardiologists in the present-day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement.
2018
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Mulukutla SR, Babb JD, Baran DA, Boudoulas KD, Feldman DN +8 more
Plain English This study looked at the evolving role of non-interventional cardiologists in cardiac catheterization labs, where both diagnostic and treatment procedures are performed. It found that these specialists, including those focused on heart failure and pulmonary hypertension, play a large part in these settings but lack quality metrics tailored to their work. Establishing a framework for measuring the quality of care provided by these cardiologists helps ensure that all patients receive high-quality treatment.
Who this helps: This benefits patients and healthcare providers working in cardiac care.
Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting.
2007
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS
Plain English This study looked at how managing blood pressure more intensively can reduce the risk of serious complications, specifically bleeding in the brain, after a procedure called carotid artery stenting (CAS). Researchers found that after implementing a new blood pressure management program, bleeding incidents dropped from 1.1% to 0%, and high-risk patients saw a significant decrease in complications from 29.4% to 4.2%. This is important because it shows that better blood pressure control can lead to safer outcomes for patients undergoing this procedure.
Who this helps: This benefits patients undergoing carotid artery stenting, especially those at higher risk of complications.
Plain English This study looked at how inflammation levels and the use of statins (cholesterol-lowering drugs) affect outcomes after heart procedures called percutaneous coronary interventions (PCI). The researchers found that patients who started taking statins before their procedure had lower inflammation levels and a lower risk of heart damage during the procedure (5.7% vs. 8.1%). Importantly, after one year, patients with high inflammation levels who took statins had a significantly lower death rate (5.7% vs. 14.8%) compared to those who did not take statins.
Who this helps: This research benefits patients undergoing heart procedures, particularly those with high inflammation.
Self-expanding stents for carotid interventions: comparison of nitinol versus stainless-steel stents.
2001
The Journal of invasive cardiology
Mukherjee D, Kalahasti V, Roffi M, Bhatt DL, Kapadia SR +5 more
Plain English This study looked at two types of stents—made from nitinol and stainless steel—used to treat narrowing of the carotid arteries in 178 patients at high risk for surgery. The results showed that both types of stents had similar rates of strokes after six months, with 3.3% for stainless steel and 2.2% for nitinol. However, more patients died in the stainless-steel group within six months, even though none of these deaths were due to neurological issues.
Who this helps: This information benefits doctors and patients deciding on the best stent option for carotid artery treatment.